🚭 GINN Initial Analysis: Commission’s TPD Evaluation Overstates Success, Undermines Harm Reduction

The Commission’s evaluation of the Tobacco Products Directive (TPD) 🎯 substantially overstates its public‑health success and fails to provide a credible evidence base for risk‑proportionate regulation of low‑risk nicotine products. 🔍 Framing & Methodology • Smoking prevalence reduction is treated as the main success metric, yet the evaluation does not convincingly isolate the TPD’s impact…

GINN Insight: Brazil and New Zealand: Policy Pathways and Smoking Outcomes

Comparative public health outcomes across countries can provide valuable insight into how regulatory frameworks shape behaviour, risk exposure, and long-term disease burden. A recent comparative analysis of Brazil and New Zealand highlights how differing policy approaches toward nicotine products are associated with divergent trends in smoking prevalence. Both countries have implemented strong tobacco control measures…